- Home
- IRON vs LADR Comparison
IRON vs LADR Comparison
Compare IRON & LADR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IRON
- LADR
- Stock Information
- Founded
- IRON 2017
- LADR 2008
- Country
- IRON United States
- LADR United States
- Employees
- IRON N/A
- LADR N/A
- Industry
- IRON Biotechnology: Pharmaceutical Preparations
- LADR Real Estate Investment Trusts
- Sector
- IRON Health Care
- LADR Real Estate
- Exchange
- IRON Nasdaq
- LADR Nasdaq
- Market Cap
- IRON 1.4B
- LADR 1.5B
- IPO Year
- IRON N/A
- LADR 2014
- Fundamental
- Price
- IRON $64.03
- LADR $11.68
- Analyst Decision
- IRON Strong Buy
- LADR Buy
- Analyst Count
- IRON 10
- LADR 6
- Target Price
- IRON $73.70
- LADR $13.33
- AVG Volume (30 Days)
- IRON 253.9K
- LADR 577.2K
- Earning Date
- IRON 11-12-2024
- LADR 02-06-2025
- Dividend Yield
- IRON N/A
- LADR 7.87%
- EPS Growth
- IRON N/A
- LADR N/A
- EPS
- IRON N/A
- LADR 0.76
- Revenue
- IRON N/A
- LADR $257,005,000.00
- Revenue This Year
- IRON N/A
- LADR N/A
- Revenue Next Year
- IRON N/A
- LADR N/A
- P/E Ratio
- IRON N/A
- LADR $15.36
- Revenue Growth
- IRON N/A
- LADR N/A
- 52 Week Low
- IRON $25.60
- LADR $10.10
- 52 Week High
- IRON $77.60
- LADR $12.48
- Technical
- Relative Strength Index (RSI)
- IRON 53.08
- LADR 48.40
- Support Level
- IRON $62.31
- LADR $11.62
- Resistance Level
- IRON $67.87
- LADR $11.97
- Average True Range (ATR)
- IRON 3.04
- LADR 0.17
- MACD
- IRON -0.46
- LADR -0.03
- Stochastic Oscillator
- IRON 38.78
- LADR 22.92
About IRON Disc Medicine Inc.
Disc Medicine Inc is a clinical-stage biopharmaceutical company that is dedicated to transforming the lives of patients with hematologic disorders. The company is building a portfolio of inventive therapeutic candidates that affect fundamental pathways of red blood cell biology. Disc Medicine is committed to developing treatments that empower and bring hope to the many patients who suffer from hematologic disease. The Company has assembled a portfolio of clinical and preclinical product candidates that aim to modify fundamental biological pathways associated with the formation and function of red blood cells, specifically heme biosynthesis and iron homeostasis.
About LADR Ladder Capital Corp
Ladder Capital Corp is an internally-managed real estate investment trust that is in commercial real estate finance. The company originates and invests in a diverse portfolio of commercial real estate and real estate-related assets, focusing on senior secured assets. The company's investment activities include: (i) Primary business of originating senior first mortgage fixed and floating rate loans collateralized by commercial real estate with flexible loan structures; (ii) owning and operating commercial real estate, including net leased commercial properties; and (iii) investing in investment-grade securities secured by first mortgage loans on commercial real estate. The company has three reportable segments include loans: which derives maximum profit; securities; and real estate.